Vicki Iassonidou has about 18 years of experience in clinical research particularly within the CRO industry. Since 2004 she has been in various positions including global in clinical trial regulatory submissions and study start-up. She has led large teams in a wide range of regulatory and study start-up activities and a variety of therapeutic areas with products including small molecules, monoclonal antibodies, somatic cells, GMOs and controlled substances. Since July 2020 she has been approved by EMA and became EUCROF’s second Product Owner (PO). She joined the Sponsor PO team which is led by Pierre Omnes and participates in the development of the EMA`s Clinical Trial Information System (CTIS) implementation supporting until go-live and thereafter.

Vicki Iassonidou holds a Master of Science degree in Biology from the University of Munich (LMU), Germany.